SUPRAFLEX-TALENT trial 3yr follow-up has been presented at EuroPCR 2021

At EuroPCR 2021  TALENT 3yrs follow up has been presented. Supraflex stent showed to be as safe and effective as Xience family stent in all-comers population.

Latest News:

EUKON FT1000 ranking 2022 on Financial Times

FT 1000: the sixth annual list of Europe’s fastest-growing companies…

Read More >

EUKON Leader della Crescita 2022

Leader della Crescita is  rank of first 450 companies, done…

Read More >

Next Generation PCI - Symposia at GISE 42, Milan 7th Oct 2021

EUKON and SMT present Next Generation PCI Symposia at GISE…

Read More >